Vincerx Pharma Inc (NASDAQ:VINC) traded at $1.71 at last check on current trade day and made an upward move of 3.64% on its previous day’s price.
Looking at the stock we see that its previous close was $1.65 with the day’s price range being $1.67 – $2.001. In terms of its 52-week price range, VINC has a high of $187.44 and a low of $1.62. The company’s stock has lost about -53.51% over that past 30 days.
Vincerx Pharma Inc has a market cap of $3.83 million and is expected to release its quarterly earnings report in February.
On the other hand, looking at the outlook for the VINC stock, short term indicators assign the stock an average of 100% Sell, while medium term indicators assign it an average of 100% Sell.
Based on estimates by 2 analysts, where scores have ranged from 1.00 for a strong buy to 5.00 for a strong sell, 0 have rated the Vincerx Pharma Inc (VINC) stock as a Hold, while 2 rate it as a Buy. 0 analyst(s) rate it as overweight while 0 of them rated it as underweight, whereas 0 suggest the stock as a Sell. The stock has an overall rating of Buy and investors could take advantage and scoop up stock of the company.
Looking further, we note the current price level is -49.84% off its SMA20 and -58.88% from its 50-day simple moving average. The RSI (14) is pointing at 30.39 while the volatility over the past week is 18.24% and jumps to 18.18% over the past one month. The beta value is 1.08, while the average true range (ATR) is currently pointing at 0.60. The average price target for the stock over the next 12 months is $2, with the estimates having a low of $2 and a high of $2. These price ends are -16.96% and -16.96% off the today’s price level respectively, although investors could be excited at the prospect of a -16.96% if the VINC share price touches on the median price of $2.
Coming back to Vincerx Pharma Inc (NASDAQ:VINC), we note that the average 3-month trading volume was 394.23K, while that of the preceding 10-day period stands at 0.26 million. Current shares outstanding are 1.57 million.
The insiders hold 17.50% of the company’s shares while institutions hold 30.24%. The data shows that short shares as of 2025-01-15, stood at 55653.0 at a short ratio of 0.05. This represents a 274.00 short interest in shares outstanding on 2025-01-15. Shares short rose in January from the previous month at 20979.0. Investors should be excited about this stock as its upside potential is great, with today’s price pushing the stock -67.47% down in year-to-date price movement.
